Found: 12
Select item for more details and to access through your institution.
Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates.
- Published in:
- PLoS Biology, 2019, v. 17, n. 6, p. 1, doi. 10.1371/journal.pbio.3000328
- By:
- Publication type:
- Article
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.772864
- By:
- Publication type:
- Article
Protection of calves by a prefusion-stabilized bovine RSV F vaccine.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0005-9
- By:
- Publication type:
- Article
A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128779
- By:
- Publication type:
- Article
Comparison of Neutralizing Antibody Responses Elicited from Highly Diverse Polyvalent Heterotrimeric HIV-1 gp140 Cocktail Immunogens versus a Monovalent Counterpart in Rhesus Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114709
- By:
- Publication type:
- Article
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00842
- By:
- Publication type:
- Article
A structural basis for immunodominant human T cell receptor recognition.
- Published in:
- Nature Immunology, 2003, v. 4, n. 7, p. 657, doi. 10.1038/ni942
- By:
- Publication type:
- Article
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 309, p. 1, doi. 10.1126/scitranslmed.aac4241
- By:
- Publication type:
- Article
A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74949-2
- By:
- Publication type:
- Article
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159709
- By:
- Publication type:
- Article
Structure and immune recognition of trimeric pre-fusion HIV-1 Env.
- Published in:
- Nature, 2014, v. 514, n. 7523, p. 455, doi. 10.1038/nature13808
- By:
- Publication type:
- Article
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 713, p. 1, doi. 10.1126/scitranslmed.adf4100
- By:
- Publication type:
- Article